The aim was to examine the early prognostic value of a combination of a continuous 12-lead ECG and troponin T in patients with chest pain and an ECG non-diagnostic for acute myocardial infarction.
Introduction
Patients admitted to hospital with chest pain vary widely regarding both diagnosis and prognosis. Eventually about one third will be discharged without and two thirds with a diagnosis of acute coronary syndromes [1] . If the ECG on admission reveals localized ST-segment elevations the diagnosis is immediate and further management can be established. In the absence of STsegment elevations, the diagnosis will be less clear but early risk stratification is very important for several reasons. Firstly, patients identified as at high risk of subsequent events need intense pharmacological treatment and should be considered for early intervention [2] . Secondly, considerable economic gains may be achieved by early identification of patients who are at sufficiently low risk for early transfer to a lower level of care and early discharge.
Several early indicators of worsening outcome have been identified in this population. Both troponin T and the admission ECG are now recognized as important predictors of both short-and long-term outcome [3] [4] [5] [6] [7] [8] [9] [10] . However, the admission ECG does not adequately reflect the dynamic nature of acute myocardial ischaemia, and previous studies have demonstrated the presence of transient ischaemic episodes, detected as ST depressions or elevations by ST-segment recording with Holter, to be a better predictor of adverse events [11, 12] . However, the Holter recording has had a limited use in clinical practice, probably due to the waiting time for off-line analysis. Recently, new technologies have been introduced, providing on-line multilead ST-segment monitoring with continuous 12-lead ECG or vectorcardiography [13, 14] . We have previously reported that on-line ST-segment monitoring with a continuous 12-lead ECG may considerably improve early risk stratification in a population with chest pain and a non-diagnostic ECG [15] . The aim of the present study was to extend these previous observations by examining the relationship between the continuous 12-lead ECG and troponin T, and the prognostic value of a combination of these two methods.
Methods

Patient selection
In the FAST study (Fast ASsessment of Thoracic pain), patients admitted to the coronary care unit at the Uppsala University hospital, were eligible for participation between March 1997 and February 1998. The inclusion criteria were a history of chest pain or other symptoms suggestive of an acute coronary syndrome, such as chest discomfort or the sudden initiation or worsening of congestive heart failure. Exclusion criteria were pre-hospital thrombolysis, the presence of STsegment elevation on the admission ECG, an ST segment uninterpretable for ischaemia (left bundle branch block [LBBB], pacemaker treatment, atrioventricular block or ventricular rhythm), previous inclusion in the present study, failure to obtain at least 9 h of ST-monitoring during the first 12 h from admission, or failure to analyse troponin T both 6 and 12 h after admission. After a run-in period of 2 months, consecutive patients were included.
Of the 1194 eligible patients, 131 were excluded due to pre-hospital thrombolysis or ST-segment elevation on the admission ECG, 170 because of previous enrolment in the study, and 90 because of an ECG uninterpretable for ischaemia (LBBB 71, pacemaker 11, atrioventricular block five, ventricular rhythm two). Out of the remaining 803 patients with an ECG non-diagnostic for acute myocardial infarction but interpretable for ischaemia, 173 patients were excluded because they had less than 9 h of monitoring, for technical reasons or the fast turnover of CCU beds, and 32 patients because of failure to analyse troponin T at both 6 and 12 h. Thus, 598 patients were included in this analysis.
All clinical data were prospectively collected and entered into the local database of the National Registry for Cardiac Intensive Care. The treatment of individual patients was left to the discretion of the individual physician. The study was approved by the local ethics committee.
Resting ECG
Standard 12-lead ECGs were obtained on admission, and interpreted by a well trained physician (T.J.) without knowledge of the outcome. ST-segment depression was defined as a lowering of the ST segment by d0·05 mV below the isoelectric line in any lead. T-wave inversion was defined as a negative or isoelectric T-wave in leads V 2 -V 6 , I and II, in aVL if R>0·5 mV and in aVF if the QRS was mostly positive.
Laboratory analysis
Blood samples were collected in EDTA-containing tubes on admission, and after 6 and 12 h. The samples were immediately centrifuged and analysed at the central laboratory. Plasma troponin T was determined by the Enzymun-Test system (Boehringer-Mannheim), with an upper reference level in healthy blood donors of 0·06 g . l 1 [16] , and plasma CK-MB(mass) was determined by a double monoclonal antibody assay on the Abbot IMx immunoanalyser (Abbott Laboratories), with an upper reference level of 5 g . l 1 . For evaluation of the prognostic value of troponin T we tested the most commonly used decision limit for myocardial damage, 0·10 g . l 1 , which is referred to as 'positive troponin T'. However, the material was also divided according to the maximum level of troponin T into the same five categories (<0·06, 0·06-0·17, 0·18-0·61, 0·62-2·11 and d2·12 g . l 1 ), as used in a previous study on the prognostic value of troponin T [8] .
ST-segment monitoring
ST-segment monitoring was performed from admission and for 12 h, using a continuous ST-segment monitoring software package, ST-Guard (Marquette Medical Systems, Milwaukee, U.S.A.). This software continuously analyses all 12 leads for ST-segment changes and stores and displays ST trends on-line with new median ECG complexes each minute. The on-line ST trends were displayed during the stay in the CCU and, hence, were known to the emergency physician.
Central analysis of ST monitoring
The ST trends were analysed centrally by a well trained physician (T.J.) without knowledge of the clinical outcome. Artifacts were removed before analysis. STsegment changes due to changes in body position were defined as sudden ST-segment changes with simultaneous changes of QRS-and T-wave amplitudes. If the first acquired ECG showed no reversible signs of ischaemia, this was chosen as the reference. Otherwise the first ECG after normalization was chosen. An ST episode was defined as a transient ST-segment depression or elevation in any lead of at least 0·1 mV compared to the reference ECG, lasting for at least 1 min. Episodes had to be separated by at least 1 min to be regarded as two separate episodes. In order to reduce the effect of heart rate, ST-segment changes were measured at J-point +(1/16 R-R interval), corresponding to J-point+60 ms at a heart rate of 62·5 beats . min 1 . The time from admission to the first episode, the number of ST episodes, the total duration of ST episodes, and the
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maximal degree of ST depression or elevation compared to the reference ECG during an episode were recorded. The recurrence of chest pain was not monitored.
Follow-up
The median follow up time was 6 months (range 1-13 months). The end-points were cardiac death, and cardiac death or myocardial infarction at 30 days and at the end of follow-up. All in-hospital events were registered in the local database of the National Registry for Cardiac Intensive Care. Only new myocardial infarctions occurring more than 24 h after admission were considered as new events. Out-of-hospital information about death and cause of death was obtained from the National Registry on Mortality. Information on myocardial infarction was obtained from the hospital diagnosis registry and patient records, and will be complete as regards information on all admissions to the only hospital providing hospital care for acute diseases for the present patient population. For the diagnosis of acute myocardial infarction, one of the following should be fulfilled; (1) pathological Q waves developing in at least two leads, (2) symptoms suggestive of acute myocardial infarction or non-diagnostic ECG changes and typical elevated levels of biochemical markers with CK-MB(mass) d10 g . l 1 , (3) symptoms suggestive of acute myocardial infarction and ST-segment elevation or LBBB but with further diagnostics not possible, or (4) signs of acute myocardial infarction at autopsy.
Statistical analysis
All data analysis was performed using the Statistical Package for Social Sciences (SPSS 8.0) software. Differences in proportions were judged by chi-square analysis using Yates' correction and by Fisher's exact test as appropriate. For non-parametric independent data the Mann-Whitney U test was used. A significant difference was considered to exist with P<0·05. To evaluate the correlation between ST episodes and the maximal value of troponin T the Spearman's rank-correlation coefficient was calculated. The Kaplan-Meier method was used to analyse the timing of events during follow-up. The end-points were cardiac death and cardiac death or myocardial infarction. Statistical assessment was performed using the log-rank test with P<0·05 considered as significant. To identify predictors of cardiac death and cardiac death or myocardial infarction, the univariate Cox regression analyses were used. The level of troponin T was categorized into the above five groups, the other variables being age d70 years (yes/no), male/ female, diabetes mellitus (yes/no), hypertension (yes/no), current smoking (yes/no), previous myocardial infarction (yes/no), previous revascularization (yes/no), ST depression d0·05 mV on the admission ECG (yes/no), ST depression d0·05 mV on the admission ECG (yes/ no), isolated T-wave inversions (yes/no), and ST episodes within 6 h of admission (yes/no). All variables with a P<0·05 were then tested in a multivariate Cox regression analysis using forward stepwise selection. Variables were entered if P<0·05 and removed if P>0·10.
Results
General findings
The baseline characteristics, findings on the admission ECG and the diagnoses within 24 h of admission are presented in Table 1 . During follow-up there were 30 (5%) deaths, of which 23 (3·8%) were cardiac deaths. Thirty-eight (6·4%) patients had a myocardial infarction. Out of the 47 patients with cardiac death or myocardial infarction, four had their event in connection to revascularization procedures.
There were no significant differences concerning baseline characteristics and clinical outcome between the analysed groups and the groups excluded because they had less than 9 h of monitoring or because of failure to analyse troponin T, except for age (70 vs 67 years, P=0·01), delay from onset of symptoms to admission (5·8 vs 5·0 h, P=0·04), ST-segment depression d0·1 mV on admission (20·1% vs 13·2%, P=0·04) and use of heparin during the acute phase (22·1% vs 13·7%, P=0·01).
The relationship between ECG on admission, troponin T and ST episodes
The cumulative incidence of troponin T d0·10 g . l 1 and ST episodes at 0, 6 and 12 h following admission in patients with normal ECGs, ST-segment depressions d0·05 mV, and other pathological ECGs on admission are listed in Table 2 . Both troponin T d0·10 g . l 1 and the presence of ST episodes were significantly more frequent in patients with, compared to without, STsegment depression on admission. Figure 1 shows the relationship between troponin T status at different time points and the presence of ST episodes during the first 6 h of ST monitoring. The quantitative relationship between ST episodes and the maximal value of troponin T is given in Table 3 .
The prognostic value of ST-segment monitoring and troponin T, 6 and 12 h after admission
The cardiac event rates at 30 days for patients with and without ST episodes, and for patients with and without a maximal value of troponin T d0·10 g . l 1 within the first 6 h after admission are presented in Table 4 . During the long-term follow-up, both the presence of ST episodes and troponin T d0·10 g . l 1 predicted a worse outcome as regards both the combined end-point cardiac death or myocardial infarction (Fig. 2) and cardiac death alone. When patients were divided into five groups according to the maximal values of troponin T there was an increased risk of subsequent cardiac death or myocardial infarction with increasing levels of troponin T (Fig. 3) .
The additional prognostic value of 12 h compared to 6 h of ST-segment monitoring and analysis of troponin T was small. Between 6 and 12 h, ST-segment monitoring identified two more patients with ST episodes, of whom none had a cardiac event. Out of the 19 patients with their first troponin T d0·10 g . l 1 at 12 h, one had a cardiac event.
The prognostic value of a combination of ST-segment monitoring and troponin T, 6 h after admission
In the multivariate analysis, the level of troponin T during the first 6 h after admission was found to be an 
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independent predictor for both end-points, while the presence of ST episodes was an independent predictor only for the double end-point (Table 5 ). The same variables came out as independent predictors when the analysis was performed at 12 h following admission. When ST-segment monitoring and troponin T status were combined, patients could be divided into low-(troponin T <0·10 g . l 1 and no ST episodes), intermediate-(troponin T d0·10 g . l 1 or ST episodes), and high-risk groups (troponin T d0·10 g . l 1 and ST episodes) as regards both short-and long-term outcome (Figs 4 and 5) .
Discussion
The present study is the first to investigate the prognostic value of a combination of troponin T and an on-line continuous 12-lead ECG. In contrast to previous studies evaluating the prognostic value of 24-48 h of STsegment recording, a shorter monitoring period was chosen. Moreover, we wanted to study a non-selected chest pain population, similar to ones dealt with in clinical practice. Accordingly, consecutive patients admitted to the CCU were included with no requirements for ECG changes on admission, excluding only patients with LBBB or a definite diagnosis based on ST-segment elevation. This was reflected by a somewhat older population and a fairly low incidence of patients with troponin T d0·10 g . l 1 (30%) and ST episodes (15%) compared to studies with more selected populations [8, 9, 11, 12, [17] [18] [19] . Our observations not only confirm but also add new knowledge to previous studies concerning the prognostic importance of troponin T and ST-segment monitoring. During short-term follow-up a troponin T d0·10 g . l 1 within the first 6 h identified all cardiac deaths. Concerning detection of cardiac death or myocardial infarction, the sensitivity and specificity for troponin T were 65% and 74%, and for ST episodes 53% and 86%, respectively. During long-term follow-up the patients could be further divided, by using several decision levels rather than a single cut-off value of troponin T, into low-, intermediate-and high-risk groups with a probability of cardiac death or myocardial infarction of 3%, 15%, 24%, respectively. Thus, this confirms a previous study in a more selected population using maximum troponin T during the first 24 h [8] , and suggests that any cut-off level used is somewhat arbitrary and that the risk of subsequent cardiac events increases gradually with increasing levels of troponin T.
The additional prognostic value of 12 h compared to 6 h of ST-segment monitoring and analyses of troponin T was small. Between 6 and 12 h, ST-segment monitoring and troponin T identified only one additional cardiac event. The use of troponin T in this manner is in accordance with two previous studies, which suggested that in addition to troponin T on admission, another sample after 4-8 h would be sufficient for adequate risk stratification [10, 20] . As regards ST-segment monitoring, there are no previous data about the optimal duration of monitoring.
When ST-segment monitoring and troponin T status were combined 6 h after admission, patients could be divided into low-(troponin T <0·10 g . l 1 and no ST episodes), intermediate-(troponin T d0·10 g . l 1 or ST episodes), and high-risk groups (troponin T d0·10 g . l 1 and ST episodes) as regards both shortand long-term outcome. In previous studies using continuous vectorcardiography, the combination of ST-segment monitoring and either CK-MB(mass) or 
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troponin T have been used to risk stratify patients in a similar way to the present study [17, 18] . However, in these studies vectorcardiographic monitoring was performed in a more selected population and for a longer time.
In the present study, there was a larger proportion of ST episodes in the group with positive troponin T on admission. Of the patients with a negative troponin T on admission but with ST episodes during monitoring, 62% developed positive troponin T at 12 h. This indicates that ST episodes and troponin T-value to some extent mirror the same pathophysiological mechanisms. However, there was only a moderate relationship between the number, duration, and degree of ST episodes and troponin T, and the fact that both came out as independent predictors in the multivariate analysis indicates that they, at least in part, reflect different aspects of the pathophysiology. It might be hypothesized that troponin T, with its wide time window is a better indicator of the instability of the disease before the patient reaches hospital. Continuous 12-lead monitoring on the other hand, might better reflect the response to the first hour of treatment. There are also suggestions that troponin T reflects thrombus formation and micro-embolization [21] , while ST-segment monitoring, to a larger extent, reflects dynamic flow variations and the severity of the coronary artery disease [11] . This is in accordance with previous studies showing that troponin T identifies patients in whom antithrombotic treatment is beneficial [22] [23] [24] , and that troponin T predicts cardiac death and myocardial infarction rather than need for revascularization [7] [8] [9] . This is also supported by the present study, in which patients with ST episodes are older and more often have a history of a prior myocardial infarction, which may indicate a more severe coronary artery disease.
There are some limitations with the present study. Firstly, out of the 803 patients with an ECG nondiagnostic of acute myocardial infarction but interpretable for ischaemia, 205 were excluded because of failure to monitor at least 9 h or failure to analyse troponin T at both 6 and 12 h. Since this was partly due to the fast turnover of CCU beds, the excluded group were somewhat healthier and younger than the analysed group. However, except for age, delay from onset of symptoms, ST-segment depression, and the use of heparin during the acute phase, there were no significant differences concerning baseline characteristics and clinical outcome. Thus, the selection bias should be small and the sample representative of patients admitted with chest pain and without ST elevation. Secondly, the individual physician had free access to the ST trends on-line and to the results of the analyses of troponin T. Hence, this may, to some extent, have influenced decisions regarding early treatment. However, this would probably cause an under-rather than over-estimation of the prognostic value of this combination. Thirdly, although the monitoring system enables on-line analysis, all the ST trends were analysed centrally off-line. Therefore, a new study is needed for evaluation of ST monitoring in clinical practice, where the individual physicians base their decision on on-line analyses. Finally, recurrence of chest pain was not recorded. However, several previous studies have convincingly demonstrated that the presence of ST episodes are a better prognostic marker than recurrence of chest pain concerning the end-points cardiac death or myocardial infarction [11, 12, [17] [18] [19] .
In conclusion, although a careful clinical evaluation can never be replaced, a combination of continuous 12-lead monitoring and troponin T seems to be a valuable tool for risk stratification during the first hours after admission in patients with chest pain and an ECG non-diagnostic of acute myocardial infarction. 
ECG and troponin T in risk stratification 1471
